Laboratory Corporation of America
Ravgen NIPT Patents Withstand Illumina Challenge
The US Patent Trial and Appeal Board delivered a pair of rulings stating that Illumina failed to show Ravgen's innovations should be considered unpatentable.
Labcorp, VieCure Collaborate on NGS, Software for Cancer Diagnosis
Startup oncology bioinformatics firm VieCure expects this collaboration to bring precision oncology diagnostics and treatment to more community clinics.
In Brief This Week:, Thermo Fisher Scientific, Agilent, Labcorp, More
News items for the week of Jan. 9, 2023.
JP Morgan Healthcare Conference, Day 2: Labcorp, Abbott, Thermo Fisher Scientific, Roche, More
Highlights from the first day included updates on several firms' COVID testing businesses, and details about a recent Thermo Fisher Scientific acquisition.
While reform of lab-developed test regulations and PAMA appeared possible at the beginning of 2022, in the end, the status quo won out.